Category bioethics
CASGEVY: Rethinking Drug Costs Through the Lens of Public Access
Maria Klimenko considers the extent to which the price of innovative treatments like CASGEVY, a type of gene therapy, should reflect not just the cost of development, but also their broader societal impact — and the public healthcare system’s ability to provide equitable access.
Climate, Health and Equity – Canada Must Lead with Action
Sharon E. Straus discusses the urgent need for the upcoming G7 summit to address climate change impacts on health.
Hope as a Moral Commitment
Jade Ealy frames hope as a moral commitment—not rooted in a feeling, but in how we choose to show up in the world and how we care for one another.




